Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian M Harding

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
ACS Infectious Diseases|October 11, 2021
Development and Immunogenicity of a Prototype Multivalent Group B <i>Streptococcus</i> Bioconjugate VaccineJeremy A Duke, Amy V Paschall, Lloyd S Robinson, et al.
The Journal of Biological Chemistry|November 7, 2025
Enhancing O-linking oligosaccharyltransferase functionality through directed evolutionRachel L Edwards, Kathleen N McAllister, Jenna C McGuffey, et al.
Life Sciences|February 11, 2016
KatG and KatE confer Acinetobacter resistance to hydrogen peroxide but sensitize bacteria to killing by phagocytic respiratory burstDaqing Sun, Sara A Crowell, Christian M Harding, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2019
A promising bioconjugate vaccine against hypervirulent <i>Klebsiella pneumoniae</i>Mario F Feldman, Anne E Mayer Bridwell, Nichollas E Scott, et al.
The Journal of Biological Chemistry|September 17, 2016
Structural Diversity in the Type IV Pili of Multidrug-resistant AcinetobacterKurt H Piepenbrink, Erik Lillehoj, Christian M Harding, et al.
Molecular Microbiology|March 3, 2015
Acinetobacter strains carry two functional oligosaccharyltransferases, one devoted exclusively to type IV pilin, and the other one dedicated to O-glycosylation of multiple proteinsChristian M Harding, Mohamed A Nasr, Rachel L Kinsella, et al.
Nature Communications|February 23, 2019
A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a hostChristian M Harding, Mohamed A Nasr, Nichollas E Scott, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Antibody responses in <i>Klebsiella pneumoniae</i> bloodstream infection: a cohort studyWontae Hwang, Paeton L Wantuch, Biana Bernshtein, et al.
The Lancet. Microbe|February 14, 2025
Antibody responses in Klebsiella pneumoniae bloodstream infection: a prospective cohort studyWontae Hwang, Paeton L Wantuch, Biana Bernshtein, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
ACS Infectious Diseases|October 11, 2021
Development and Immunogenicity of a Prototype Multivalent Group B <i>Streptococcus</i> Bioconjugate VaccineJeremy A Duke, Amy V Paschall, Lloyd S Robinson, et al.
The Journal of Biological Chemistry|November 7, 2025
Enhancing O-linking oligosaccharyltransferase functionality through directed evolutionRachel L Edwards, Kathleen N McAllister, Jenna C McGuffey, et al.
Life Sciences|February 11, 2016
KatG and KatE confer Acinetobacter resistance to hydrogen peroxide but sensitize bacteria to killing by phagocytic respiratory burstDaqing Sun, Sara A Crowell, Christian M Harding, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2019
A promising bioconjugate vaccine against hypervirulent <i>Klebsiella pneumoniae</i>Mario F Feldman, Anne E Mayer Bridwell, Nichollas E Scott, et al.
The Journal of Biological Chemistry|September 17, 2016
Structural Diversity in the Type IV Pili of Multidrug-resistant AcinetobacterKurt H Piepenbrink, Erik Lillehoj, Christian M Harding, et al.
Molecular Microbiology|March 3, 2015
Acinetobacter strains carry two functional oligosaccharyltransferases, one devoted exclusively to type IV pilin, and the other one dedicated to O-glycosylation of multiple proteinsChristian M Harding, Mohamed A Nasr, Rachel L Kinsella, et al.
Nature Communications|February 23, 2019
A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a hostChristian M Harding, Mohamed A Nasr, Nichollas E Scott, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Antibody responses in <i>Klebsiella pneumoniae</i> bloodstream infection: a cohort studyWontae Hwang, Paeton L Wantuch, Biana Bernshtein, et al.
The Lancet. Microbe|February 14, 2025
Antibody responses in Klebsiella pneumoniae bloodstream infection: a prospective cohort studyWontae Hwang, Paeton L Wantuch, Biana Bernshtein, et al.
Pageof 3